Viewing Study NCT06527404


Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2026-01-04 @ 12:54 AM
Study NCT ID: NCT06527404
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2024-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module